NMR-based drug design of the entry inhibitor of SARS-CoV-2 targeting the interaction between SARS-CoV-2 spike protein and hACE2

○Mariko Yokogawa

[28P2-am1-018] NMR-based drug design of the entry inhibitor of SARS-CoV-2 targeting the interaction between SARS-CoV-2 spike protein and hACE2

○Mariko Yokogawa¹, Mahoro Horiuchi¹, Syunki Kaneichi¹, Taiga Otake¹, Tomoki Yonezawa¹, Yugo Shimizu¹, Kazuyoshi Ikeda^1,2, Yuichiro Yamamoto³, Shota Sakai⁴, Kohji Noguchi³, Masayoshi Fukasawa⁴, Masanori Osawa¹ (1. Fac. Pharm., Keio Univ., 2. RIKEN, 3. Pharm. Sci., Tokyo Univ. of Sci., 4. NIID)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[28P2-am1] Informatics, in silico chemistry (computational chemistry)/Structural biology/Others

[28P2-am1-018] NMR-based drug design of the entry inhibitor of SARS-CoV-2 targeting the interaction between SARS-CoV-2 spike protein and hACE2

Password